Douglas Dachille
Directeur/Membre du Conseil chez BRIDGEBIO PHARMA, INC.
Fortune : 506 600 $ au 30/06/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Neil Kumar | M | 45 |
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 9 ans |
| Peter Zaffino | M | 57 | 7 ans | |
| Charles Homcy | M | 75 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 9 ans |
| Richard Scheller | M | 70 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 6 ans |
| Amy Schulman | F | 63 |
Lyndra Therapeutics, Inc.
 Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 9 ans |
| Sabra Purtill | F | 61 | 5 ans | |
| Jessica Ballinger | F | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 8 ans |
| Eric Aguiar | M | 62 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 5 ans |
| Patricia Hurter | M | 60 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | - |
| Ronald Daniels | M | 64 | 9 ans | |
| Ali Satvat | M | 46 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 8 ans |
| Andrew Lo | M | 63 | 9 ans | |
| Mark Gus Alexandridis | M | 66 |
First Principles Capital Management LLC
 First Principles Capital Management LLC Investment ManagersFinance First Principles Capital Management LLC (FPCM) is a registered investment advisor headquartered in New York City. The firm was founded in 2003 by Richard F. Dolan, Douglas A. Dachille and James H. van Epps. In 2015, they were acquired by AIG Capital Corp., a wholly owned subsidiary of American International Group, Inc. (NYSE: AIG). FPCM provides investment advisory and asset management services to affiliated and unaffiliated institutional clients. The firm provides customized separately managed accounts and targeted funds for endowments and foundations, financial institutions, corporations, pension funds, family offices, high net worth individuals, and trusts. | 19 ans |
| Brenton Saunders | M | 56 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 4 ans |
| Francis McCormick | M | 73 | 9 ans | |
| Jonathan Fox | M | 66 | - | |
| Richard Francis Dolan | M | 65 |
First Principles Capital Management LLC
First Principles Capital Management LLC Investment ManagersFinance First Principles Capital Management LLC (FPCM) is a registered investment advisor headquartered in New York City. The firm was founded in 2003 by Richard F. Dolan, Douglas A. Dachille and James H. van Epps. In 2015, they were acquired by AIG Capital Corp., a wholly owned subsidiary of American International Group, Inc. (NYSE: AIG). FPCM provides investment advisory and asset management services to affiliated and unaffiliated institutional clients. The firm provides customized separately managed accounts and targeted funds for endowments and foundations, financial institutions, corporations, pension funds, family offices, high net worth individuals, and trusts. | 21 ans |
| Brian Stephenson | M | 43 | 6 ans | |
| Carlo Traverso | M | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 9 ans |
| Kathleen Carbone | F | 52 | 8 ans | |
| Hannah Valantine | M | 72 | 3 ans | |
| Andrea Ellis | F | 38 | 3 ans | |
| Peter Porrino | M | 67 | 5 ans | |
| Jennifer Silane | F | - | 3 ans | |
| James Cole | M | 55 | 3 ans | |
| Fred Hassan | M | 78 | 3 ans | |
| Randal Scott | M | 66 | 4 ans | |
| Jennifer Cook | F | 58 |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 5 ans |
| Robert Langer | M | 74 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 9 ans |
| Catherine Reynolds | F | 66 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | - |
| Uma Sinha | M | 67 | 8 ans | |
| Christine Siu | F | 47 | 4 ans | |
| Vikram Bali | M | - | - | |
| Julia Chapman | F | - |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | - |
| Ashish Singh | M | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 1 ans |
| Jillian Moo-Young | F | - |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 3 ans |
| Claude Wade | M | 56 | 3 ans | |
| Jennifer Waldner | F | - | 5 ans | |
| Rohan Nirody | M | - |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | - |
| Graeme I. Bell | M | - |
The University of Chicago
| 38 ans |
| Jamie Miller | M | - | 6 ans | |
| Quentin McMillan | M | - | 3 ans | |
| Edward M. Levin | M | - | 5 ans | |
| Jim Momtazee | M | - |
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | 8 ans |
| Zafrira Avnur | M | 73 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | - |
| Thomas Lillelund | M | - | 4 ans | |
| Michelle LeBeau | M | 70 |
The University of Chicago
| 38 ans |
| Richard Scranton | M | 57 |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | 4 ans |
| Matthew Outten | M | 49 | 5 ans | |
| Stephen Roderick Miller | M | - |
First Principles Capital Management LLC
First Principles Capital Management LLC Investment ManagersFinance First Principles Capital Management LLC (FPCM) is a registered investment advisor headquartered in New York City. The firm was founded in 2003 by Richard F. Dolan, Douglas A. Dachille and James H. van Epps. In 2015, they were acquired by AIG Capital Corp., a wholly owned subsidiary of American International Group, Inc. (NYSE: AIG). FPCM provides investment advisory and asset management services to affiliated and unaffiliated institutional clients. The firm provides customized separately managed accounts and targeted funds for endowments and foundations, financial institutions, corporations, pension funds, family offices, high net worth individuals, and trusts. | 20 ans |
| Christine Seidman | M | 71 | - | |
| James Momtazee | M | 52 | 8 ans | |
| Eric Michael David | M | 56 | - | |
| Jeff M. Clements | M | - | 5 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Peter Hancock | M | 65 | 7 ans | |
| Brian Duperreault | M | 76 | 4 ans | |
| Luciana Fato | F | 57 | - | |
| Michael Frankel | M | 56 |
The University of Chicago
| 9 ans |
| Siddhartha Sankaran | M | 46 | 8 ans | |
| Jeffrey Hurd | M | 56 | 19 ans | |
| Rose Glazer | F | 57 | 7 ans | |
| Mark Lyons | M | 67 | 5 ans | |
| David Herzog | M | 64 | 16 ans | |
| Stephen Bardin | M | 34 | 3 ans | |
| Shane Fitzsimons | M | 56 | 4 ans | |
| Maag Macia | F | 55 | 7 ans | |
| Chang-Jin Moon | M | 71 |
The University of Chicago
| 2 ans |
| Elizabeth A. Werner | F | - | 8 ans | |
| Donnalee DeMaio | F | 65 | 5 ans | |
| Alok Gaur | M | - |
The University of Chicago
| 6 ans |
| Jeremy Feigelson | M | - |
The University of Chicago
| 3 ans |
| Carla N. Taylor | F | - |
The University of Chicago
| 6 ans |
| John Paulson | M | 68 | 1 ans | |
| Ronald Rittenmeyer | M | 76 | 9 ans | |
| Catherine Stehman-Breen | M | 61 |
The University of Chicago
| 3 ans |
| Thomas Leonardi | M | 70 | - | |
| Jonathan Wismer | M | 52 | 2 ans | |
| Michael Booth | M | - |
The University of Chicago
| 7 ans |
| Michael Nissen | M | - |
Albany Medical College
| 4 ans |
| Emily Garbaccio | F | - | - | |
| Stanley Ryan | M | 62 |
The University of Chicago
| 2 ans |
| Bill Bergman | M | - |
The University of Chicago
| 3 ans |
| Andrew Alford | M | - |
The University of Chicago
| 6 ans |
| Suzanne Johnson | F | 66 | 12 ans | |
| George L. Miles | M | 82 | 12 ans | |
| David Abramson | M | - |
The University of Chicago
| 2 ans |
| Jim Sanderson | M | - |
The University of Chicago
| 4 ans |
| Theresa M. Stone | F | 79 | 6 ans | |
| Tom Motamed | M | 75 | 4 ans | |
| Luis Alberto Mañas Antón | M | 65 |
The University of Chicago
| 4 ans |
| Igal Litovsky | M | - |
The University of Chicago
| 4 ans |
| Mark Phelan | M | 55 |
The University of Chicago
| 3 ans |
| Spiro Voulgaris | M | - |
The University of Chicago
| 9 ans |
| Henry Stephen Miller | M | 78 | 11 ans | |
| Mark Nydam | M | - |
The University of Chicago
| 3 ans |
| Jeffrey Gulcher | M | - |
The University of Chicago
| 7 ans |
| Thomas A. Russo | M | 80 | 6 ans | |
| Richard C. Wirthlin | M | - |
The University of Chicago
| 3 ans |
| Samuel Merksamer | M | 43 | 2 ans | |
| Peter Ryerson Fisher | M | 67 | 4 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Douglas Dachille
- Réseau Personnel
